Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review
Abstract
How to manage patients with prostate cancer (PCa) with biochemical recurrence (BCR) following primary curative treatment is a controversial issue. Importantly, this prostate-specific antigen (PSA)-only recurrence is a surrogate neither of PCa-specific survival nor of overall survival. Physicians are therefore challenged with preventing or delaying the onset of clinical progression in those deemed at risk, while avoiding over-treating patients...
Paper Details
Title
Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review
Published Date
Nov 21, 2017
Journal
Volume
100
Issue
3
Pages
251 - 262
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History